HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by V. Sakharov, D. Articles by Rijken, D. C. Search for Related Content PubMed PubMed Citation Articles by V. Sakharov, D. Articles by Rijken, D. C. Social Bookmarking                      What's this?

Volume 271, Number 44, Issue of November 1, 1996 pp. 27912-27918
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Interactions between Staphylokinase, Plasmin(ogen), and Fibrin
STAPHYLOKINASE DISCRIMINATES BETWEEN FREE PLASMINOGEN AND PLASMINOGEN BOUND TO PARTIALLY DEGRADED FIBRIN

(Received for publication, May 24, 1996, and in revised form, July 18, 1996)

Dmitry V. Sakharov , H. Roger Lijnen ^¶ and Dingeman C. Rijken

From the  Gaubius Laboratory, TNO Prevention and Health, P. O. Box 2215, 2301 CE Leiden, The Netherlands and the ^¶ Center for Molecular and Vascular Biology, University of Leuven, B-3000 Leuven, Belgium

Staphylokinase (STA), a protein of bacterial origin, induces highly fibrin-specific thrombolysis both in human plasma in vitro and in pilot clinical trials. Using fluorescence microscopy, we investigated the spatial distribution of fluorescein isothiocyanate (FITC)-labeled STA during lysis of a plasma clot and its binding to purified fibrin clots in the presence or in the absence of plasmin(ogen). STA highly accumulated in a thin superficial layer of the lysing plasma clot following the distribution of plasminogen (Pg) during lysis. Experiments with purified fibrin clots revealed that STA binds to Pg bound to partially degraded fibrin but not to Pg bound to intact fibrin. Binding of FITC-labeled STA to various forms of plasmin(ogen) in a buffer solution was studied by measuring fluorescence anisotropy. The binding constant for Glu-Pg was estimated as 7.4 µM and for Lys-Pg as 0.28 µM; for active-site blocked plasmin the binding constant was less than 0.05 µM. The much lower affinity of STA for Glu-Pg compared with that for active site-blocked plasmin was mainly due to a lower association rate constant, as assessed by real time biospecific interaction analysis. Gel filtration of a mixture of STA with a molar excess of Glu-Pg demonstrated that STA migrated as an unbound 18-kDa protein when activation of Pg into plasmin was precluded by inhibitors of plasmin. When gel-filtered under the same conditions with plasmin, STA migrated in complex with plasmin with an apparent molecular mass of 100 kDa. Confocal fluorescence microscopy finally demonstrated that when FITC-labeled STA was added to plasma before clotting, it did not bind to fibrin fibers during the first minutes (lag phase), although Pg bound to the fibers moderately. Then, both Pg and STA started to accumulate on the fibers progressively, followed by complete lysis of the clot. In conclusion, our results imply that, when STA is added to plasma, only a small percentage associates with Pg. In contrast, STA binds strongly to plasmin and to Pg, which is bound to partially degraded fibrin. These findings add a new mechanism to the known explanations for the inefficient Pg activation by STA in plasma and specify the mechanism for fibrin-dependent activation of Pg.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				T. Jin, M. Bokarewa, T. Foster, J. Mitchell, J. Higgins, and A. Tarkowski Staphylococcus aureus Resists Human Defensins by Production of Staphylokinase, a Novel Bacterial Evasion Mechanism J. Immunol., January 15, 2004; 172(2): 1169 - 1176. [Abstract] [Full Text] [PDF]

				Q. Lian, S. J. Szarka, K. K. S. Ng, and S.-L. Wong Engineering of a Staphylokinase-based Fibrinolytic Agent with Antithrombotic Activity and Targeting Capability toward Thrombin-rich Fibrin and Plasma Clots J. Biol. Chem., July 11, 2003; 278(29): 26677 - 26686. [Abstract] [Full Text] [PDF]

				S.-C. Wu, F. J. Castellino, and S.-L. Wong A Fast-acting, Modular-structured Staphylokinase Fusion with Kringle-1 from Human Plasminogen as the Fibrin-targeting Domain Offers Improved Clot Lysis Efficacy J. Biol. Chem., May 9, 2003; 278(20): 18199 - 18206. [Abstract] [Full Text] [PDF]

				I. P. Gladysheva, I. Y. Sazonova, S. A. Chowdhry, L. Liu, R. B. Turner, and G. L. Reed Chimerism Reveals a Role for the Streptokinase beta -Domain in Nonproteolytic Active Site Formation, Substrate, and Inhibitor Interactions J. Biol. Chem., July 19, 2002; 277(30): 26846 - 26851. [Abstract] [Full Text] [PDF]

				L. Bajzar Thrombin Activatable Fibrinolysis Inhibitor and an Antifibrinolytic Pathway Arterioscler. Thromb. Vasc. Biol., December 1, 2000; 20(12): 2511 - 2518. [Abstract] [Full Text] [PDF]

				B. Schlott, K.-H. Guhrs, M. Hartmann, A. Rocker, and D. Collen NH2-terminal Structural Motifs in Staphylokinase Required for Plasminogen Activation J. Biol. Chem., August 28, 1998; 273(35): 22346 - 22350. [Abstract] [Full Text] [PDF]

				D. V. Sakharov, E. F. Plow, and D. C. Rijken On the Mechanism of the Antifibrinolytic Activity of Plasma Carboxypeptidase B J. Biol. Chem., May 30, 1997; 272(22): 14477 - 14482. [Abstract] [Full Text] [PDF]

				B. Schlott, K.-H. Guhrs, M. Hartmann, A. Rocker, and D. Collen Staphylokinase Requires NH2-terminal Proteolysis for Plasminogen Activation J. Biol. Chem., February 28, 1997; 272(9): 6067 - 6072. [Abstract] [Full Text] [PDF]